Regarding bone-targeted therapies, teriparatide (TPTD), a recombinant parathyroid hormone (1–34) approved for the treatment of osteoporosis [75], seems to improve bone pain and benefit the healing of fracture and pseudofractures in adults with HPP [76,77]. This evidence concerns the gene PTH and osteoporosis.